Pilot Investigation of a Multinutrient Supplement on Skin Aging and Aging Metabolites in Healthy Women

This study has been completed.

First Received on October 5, 2007. Last Updated on January 14, 2009 History of Changes

Sponsor:	Stanford University
Collaborator:	Nu Skin Enterprises
Information provided by:	Stanford University
ClinicalTrials.gov Identifier:	NCT00541931

Purpose

We are seeking healthy female volunteers to determine if multinutrient supplementation affects visible signs of skin aging as well as blood measurements of aging. We are seeking smokers and non-smokers.

Condition	Intervention
Skin Diseases	Drug: Dietary Supplement: LifePak Nano

Study Type:	Interventional
Study Design:	Allocation: Non-Randomized Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment
Official Title:	Pilot Investigation of a Multinutrient Supplement on Skin Aging and Aging Metabolites in Healthy Women

Resource links provided by NLM:

MedlinePlus related topics: Dietary Supplements Skin Aging Skin Conditions

U.S. FDA Resources

Further study details as provided by Stanford University:

Primary Outcome Measures:

Determine whether supplementation affects skin aging

Secondary Outcome Measures:

Determine if supplementation affects blood markers of aging

Estimated Enrollment:

Eligibility

Ages Eligible for Study:	18 Years to 70 Years
Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:- Fitzpatrick Skin type I or II

Nonpregnant Females, age 18-30 or 50-70
Body Mass Index Normal or Overweight
If age 18-30, must be non-smoker
Willing to fast for 8 hours prior to a blood draw
 Exclusion Criteria:- History of cosmetic surgery
Use of anti-aging medications within 3 months of enrollment
Use of over-the-counter anti-aging creams (not sunscreens) more than once per week within one month of enrollment
Use of dietary supplements including vitamins within one month of enrollment
Use of tanning beds or excessive UV exposure (greater than 2 hours per day) within one month of enrollment
Use of sunless tanners within one month of enrollment
Uncontrolled or ongoing serious medical condition
Participation in another clinical study involving use of an investigational drug or product
Medical condition which, at the discretion of the investigator, will have a significant impact on ability to judge participant's skin characteristics, including age.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00541931

Locations

United States, California
Stanford University School of Medicine
Stanford, California, United States, 94305

Sponsors and Collaborators

Stanford University

Nu Skin Enterprises

Investigators

Principal Investigator:

Dr. Anne Lynn S. Chang

Stanford University

More Information

No publications provided

ClinicalTrials.gov Identifier:	NCT00541931 History of Changes
Other Study ID Numbers:	10622
Study First Received:	October 5, 2007
Last Updated:	January 14, 2009
Health Authority:	United States: Institutional Review Board

Additional relevant MeSH terms:

Skin Diseases

ClinicalTrials.gov processed this record on February 09, 2012